ISSN 2996-8380
Vol. Scholarly Debut, Issue Summer 2026, 2026June 30, 2026 CEST
Analysis of Reported Adverse Events for Carmustine Delivered Systematically versus Locally by Gliadel for Malignant Brain Tumors
Analysis of Reported Adverse Events for Carmustine Delivered Systematically versus Locally by Gliadel for Malignant Brain Tumors
Articles in Vol. Scholarly Debut, Issue Summer 2026, 2026
Vol. Scholarly Debut, Issue Summer 2026, 2026
- Analysis of Reported Adverse Events for Carmustine Delivered Systematically versus Locally by Gliadel for Malignant Brain TumorsDavid Hu
- Investigating to what extent learning hours affect students’ GPA through a comparison of linear regression and neural-network machine learning modelsJinmo Wu
- Global Perspectives on Bell’s Palsy: A Cross-Country Analysis of Therapeutic ApproachesAndrew Liu
- Breathing Beneath the Surface: A Review of Airborne Toxins in Indoor PoolsCamryn E. Williams
- The Impacts of the COVID-19 Pandemic and 2023 WGA and SAG-AFTRA Labour Stoppages on Toronto’s Film IndustryLeila Popatia
- Examining Water Safety and Innovative Alternative Solutions: A Case Study of the Himalayan Nation of NepalIris Xu
- Storming the Global Castle: Property Defense, Dispossession, and the Legality of the 2026 Maduro CaptureRobert Z. Guo
- Fantasy Urbanism: Theme Parks as Blueprints for Better CitiesIrene Yitan Xue
- From Financial Exclusion to Inclusion: Using Microfinance to Address Credit InvisibilityJiajun XuHannah Hou
- An Overview of Gene Therapy in CardiomyopathiesKrisha Patel
Hu, David. 2026. “Analysis of Reported Adverse Events for Carmustine Delivered Systematically versus Locally by Gliadel for Malignant Brain Tumors.” Scholarly Review Journal Scholarly Debut (Summer 2026). https://doi.org/10.70121/001c.163254.